Clinical Trial Update: Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sintilimab after concurrent chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Cancer, Chemoradiotherapy | Phase 2 | Status: RECRUITING